We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Warning Letter Roundup: FDA Scolds Drugmakers for Quality Violations
Warning Letter Roundup: FDA Scolds Drugmakers for Quality Violations
The FDA hit two U.S. and one Taiwanese drugmaker for a variety of shortcomings at their facilities, including quality oversight, inadequate testing and faulty equipment.